We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
Cap. Flow
-$982M
Cap. Flow %
-2.08%
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Consumer Discretionary 15.92%
3 Financials 12.69%
4 Healthcare 12.47%
5 Communication Services 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOP icon
801
Koppers
KOP
$969M
$7K ﹤0.01%
166
-63
-28% -$2.77K
MYGN icon
802
Myriad Genetics
MYGN
$312M
$7K ﹤0.01%
231
-922
-80% -$31.2K
RGEN icon
803
Repligen
RGEN
$9.25B
$7K ﹤0.01%
182
SWX icon
804
Southwest Gas
SWX
$6.67B
$7K ﹤0.01%
106
TGI
805
DELISTED
Triumph Group
TGI
$7K ﹤0.01%
264
UTL icon
806
Unitil
UTL
$980M
$7K ﹤0.01%
149
VNDA icon
807
Vanda Pharmaceuticals
VNDA
$302M
$7K ﹤0.01%
+391
New +$6.54K
GTS
808
DELISTED
Triple-S Management Corporation
GTS
$7K ﹤0.01%
294
-330
-53% -$7.87K
AXE
809
DELISTED
Anixter International Inc
AXE
$7K ﹤0.01%
93
PAY
810
DELISTED
Verifone Systems Inc
PAY
$7K ﹤0.01%
476
-1,566
-77% -$27.3K
DCT
811
DELISTED
DCT Industrial Trust Inc.
DCT
$7K ﹤0.01%
+124
New +$7.01K
FNSR
812
DELISTED
Finisar Corp
FNSR
$7K ﹤0.01%
+452
New +$8.53K
ANIP icon
813
ANI Pharmaceuticals
ANIP
$1.78B
$6K ﹤0.01%
108
NWLI
814
DELISTED
National Western Life Group, Inc. Class A
NWLI
$6K ﹤0.01%
20
STOR
815
DELISTED
STORE Capital Corporation
STOR
$6K ﹤0.01%
+241
New +$5.85K
LDL
816
DELISTED
Lydall, Inc.
LDL
$6K ﹤0.01%
+130
New +$6.24K
ANIK icon
817
Anika Therapeutics
ANIK
$287M
$4K ﹤0.01%
79
OSPN icon
818
OneSpan
OSPN
$618M
$4K ﹤0.01%
314
-246
-44% -$3.36K
VVX icon
819
V2X
VVX
$2.65B
$4K ﹤0.01%
105
PFC
820
DELISTED
Premier Financial Corp. Common Stock
PFC
$4K ﹤0.01%
144
NKTR icon
821
Nektar Therapeutics
NKTR
$2.58B
$3K ﹤0.01%
+2
New +$2.58K
PEBO icon
822
Peoples Bancorp
PEBO
$1.47B
$3K ﹤0.01%
+84
New +$2.94K
TCBK icon
823
TriCo Bancshares
TCBK
$1.83B
$3K ﹤0.01%
68
EGP icon
824
EastGroup Properties
EGP
$10.9B
$2K ﹤0.01%
+24
New +$2K
SIR
825
DELISTED
SELECT INCOME REIT
SIR
$2K ﹤0.01%
+243
New +$2.22K

Similar funds

Loomis, Sayles & Company's Q1 2018 Portfolio in Review

As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
  • Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
  • Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
  • Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
  • Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
  • Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
  • Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.

Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.